TARIQ SHAFI to Prospective Studies
This is a "connection" page, showing publications TARIQ SHAFI has written about Prospective Studies.
Connection Strength
0.856
-
Trajectories of Uremic Symptom Severity and Kidney Function in Patients with Chronic Kidney Disease. Clin J Am Soc Nephrol. 2022 04; 17(4):496-506.
Score: 0.084
-
A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. Kidney Int. 2022 02; 101(2):369-378.
Score: 0.083
-
Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2017 Jul; 70(1):48-58.
Score: 0.059
-
Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol. 2017 Jan; 28(1):321-331.
Score: 0.057
-
Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrol. 2016 Feb 20; 17:18.
Score: 0.055
-
Estimating residual kidney function in dialysis patients without urine collection. Kidney Int. 2016 May; 89(5):1099-1110.
Score: 0.055
-
Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2014 Sep; 64(3):443-51.
Score: 0.049
-
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2013 Jun; 36(6):1522-33.
Score: 0.044
-
Serum ?-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1435-45.
Score: 0.043
-
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010 Aug; 56(2):348-58.
Score: 0.037
-
Frailty, Age, and Postdialysis Recovery Time in a Population New to Hemodialysis. Kidney360. 2021 09 30; 2(9):1455-1462.
Score: 0.020
-
Kidney Disease Symptoms before and after Kidney Transplantation. Clin J Am Soc Nephrol. 2021 07; 16(7):1083-1093.
Score: 0.020
-
Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2022 01; 79(1):36-44.e1.
Score: 0.020
-
Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2021 03; 32(3):639-653.
Score: 0.019
-
Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 06; 77(6):907-919.
Score: 0.019
-
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
Score: 0.018
-
Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression. JAMA Intern Med. 2019 04 01; 179(4):542-551.
Score: 0.017
-
Vascular Calcification Markers and Hemodialysis Vascular Access Complications. Am J Nephrol. 2018; 48(5):330-338.
Score: 0.017
-
Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. BMC Nephrol. 2018 06 26; 19(1):150.
Score: 0.016
-
Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2017 Sep; 70(3):337-346.
Score: 0.015
-
Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis. Am J Kidney Dis. 2016 Nov; 68(5):743-751.
Score: 0.014
-
Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Aug 07; 16:131.
Score: 0.013
-
Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Apr 24; 16:63.
Score: 0.013
-
Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014 Dec; 64(6):954-61.
Score: 0.013
-
Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr; 9(4):745-55.
Score: 0.012
-
Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med. 2014 Feb; 29(2):290-7.
Score: 0.012
-
Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol. 2013 Jun 27; 14:134.
Score: 0.012
-
Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 2011 May; 93(5):1087-91.
Score: 0.010
-
Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med. 2010 Oct 25; 170(19):1745-51.
Score: 0.010